ILMN
32
-9
BK
74
3
SLB
52
-3
XOM
42
-6
FIS
51
-4
LRCX
37
-9
VRSK
68
-12
JBHT
56
-3
CSX
57
-4
SWKS
38
-2
HRL
35
-3
HUM
41
-4
KMX
61
-3
IR
63
-3
ORCL
63
-4
WM
74
-5
HBI
58
3
CMI
64
-3
CB
57
2
MRO
50
4
ILMN
32
-9
BK
74
3
SLB
52
-3
XOM
42
-6
FIS
51
-4
LRCX
37
-9
VRSK
68
-12
JBHT
56
-3
CSX
57
-4
SWKS
38
-2
HRL
35
-3
HUM
41
-4
KMX
61
-3
IR
63
-3
ORCL
63
-4
WM
74
-5
HBI
58
3
CMI
64
-3
CB
57
2
MRO
50
4
Financhill
Back

Adaptimmune Therapeutics PLC Stock Predictions

Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term

See if stocks could soar as much as 1,000% if history repeats itself.
Sell
4

ADAP
Adaptimmune Therapeutics PLC

Last Price:
0.59
Seasonality Move:
50.57%

7 Day Trial

ALL ACCESS PASS

$ 7

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.

Adaptimmune Therapeutics PLC Stock Forecast

  • Is Adaptimmune Therapeutics PLC Stock Undervalued?
    The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.59. The Score for ADAP is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will Adaptimmune Therapeutics PLC Stock Go Up Next Year?

Data Unavailable

Adaptimmune Therapeutics PLC Stock Rating

Data Unavailable

Adaptimmune Therapeutics PLC Stock Price History

Is ADAP stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United Kingdom
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
adaptimmune.com

52-Week Data

52-Week High:
2.05
52-Week Low:
0.42

Prediction Charts

Market Cap:
150.1M
Price in USD:
0.59
Volume:
3.39M
Beta:
2.15

Technical Analysis

SMA50:
0.88
SMA100:
1.02
SMA200:
1.13
52-Wk Change:
17.32%

Stock Predictions

  • Is Adaptimmune Therapeutics PLC stock public?
    Yes, Adaptimmune Therapeutics PLC is a publicly traded company.
  • What is the Adaptimmune Therapeutics PLC stock quote today?
    The Adaptimmune Therapeutics PLC stock price is 0.59 USD today.
  • How to buy Adaptimmune Therapeutics PLC stock online?
    You can buy Adaptimmune Therapeutics PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-29 0.74 0.70 0.75 0.70
Oct-30 0.70 0.70 0.72 0.67
Oct-31 0.71 0.73 0.75 0.70
Nov-1 0.73 0.80 0.82 0.73
Nov-4 0.80 0.81 0.86 0.78
Nov-5 0.82 0.83 0.83 0.79
Nov-6 0.82 0.83 0.86 0.79
Nov-7 0.82 0.78 0.83 0.77
Nov-8 0.78 0.80 0.80 0.75
Nov-11 0.81 0.82 0.83 0.78
Nov-12 0.82 0.79 0.82 0.76
Nov-13 0.82 0.77 0.83 0.75
Nov-14 0.81 0.59 0.81 0.58
Nov-15 0.59 0.59 0.61 0.58

Adaptimmune Therapeutics PLC Earnings

Data Unavailable

Adaptimmune Therapeutics PLC Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and a decrease next year of $0.33 per share.

* Adaptimmune Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.